The use of cyclooxygenase-2 inhibitors for improvement of efficacy of radiotherapy in cancers

E Salehifar, SJ Hosseinimehr - Drug Discovery Today, 2016 - Elsevier
Highlights•COX-2 is overexpressed in tumour cells and is involved in cell proliferation and
progression and angiogenesis.•COX-2 inhibitors can block various signalling pathways …
被引用次数：63 相关文章

[引用][C] The use of cyclooxygenase-2 inhibitors for improvement of efficacy of radiotherapy in cancers

E Salehifar, SJ Hosseinimehr - Drug Discovery Today, 2016 - cir.nii.ac.jp
The use of cyclooxygenase-2 inhibitors for improvement of efficacy of radiotherapy in
cancers | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 …

The use of cyclooxygenase-2 inhibitors for improvement of efficacy of radiotherapy in cancers

E Salehifar, SJ Hosseinimehr - Drug Discovery Today, 2016 - infona.pl
Cyclooxygenase-2 (COX-2) is overexpressed in cancer cells and is associated with
carcinogenesis and maintenance of progressive tumour growth as well as resistance of …

The use of cyclooxygenase-2 inhibitors for improvement of efficacy of radiotherapy in cancers.

E Salehifar, SJ Hosseinimehr - Drug Discovery Today, 2016 - europepmc.org
Cyclooxygenase-2 (COX-2) is overexpressed in cancer cells and is associated with
carcinogenesis and maintenance of progressive tumour growth as well as resistance of …

The use of cyclooxygenase-2 inhibitors for improvement of efficacy of radiotherapy in cancers

E Salehifar, SJ Hosseinimehr - Drug discovery today, 2016 - pubmed.ncbi.nlm.nih.gov
Cyclooxygenase-2 (COX-2) is overexpressed in cancer cells and is associated with
carcinogenesis and maintenance of progressive tumour growth as well as resistance of …